Dr Roberto A Arguello, MD | |
1910 S 1st St, Suite 100, Mcallen, TX 78503-1255 | |
(956) 687-8475 | |
(956) 687-4663 |
Full Name | Dr Roberto A Arguello |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1910 S 1st St, Mcallen, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538130521 | NPI | - | NPPES |
110250102 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | G6260 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Roberto A Arguello, MD 1910 S 1st St, Suite 100, Mcallen, TX 78503-1255 Ph: (956) 687-8475 | Dr Roberto A Arguello, MD 1910 S 1st St, Suite 100, Mcallen, TX 78503-1255 Ph: (956) 687-8475 |
News Archive
AmpliPhi BioSciences Corporation, the leader in the development of bacteriophage-based antibacterial therapies to treat antibiotic resistant infections, announces it has entered into Collaboration and License Agreements with UK-based University of Leicester to develop a novel bacteriophage therapy targeting Clostridium difficile, a serious gastrointestinal infection for which new treatments are urgently required.
The Montreal Neurological Institute of McGill University, a world-leading institution focused on brain research and advanced patient care, and Thermo Fisher Scientific, the world leader in serving science, today announce an agreement designed to accelerate the understanding of neurological disease by focusing on about 30 proteins associated with Parkinson's disease, amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegias, epileptic encephalopathies and ataxias, which are all devastating brain diseases.
Cornerstone Pharmaceuticals Inc., a privately held, clinical stage oncology-focused pharmaceutical company, has announced the closing of its Series B-4 private equity financing of $6,175,000. The Company plans to use the proceeds for its on-going phase I/II clinical trials of its lead cancer drug-CPI-613, research and development, and general corporate purposes.
A University of Michigan lab focused on developing cutting-edge methods to inform effective interventions for drug abuse, HIV and other chronic conditions has been awarded a $13.2 million grant from the National Institute on Drug Abuse.
A team of researchers led by Nanyang Technological University, Singapore (NTU Singapore) has developed a device that offers a quicker and less invasive way to seal tears and holes in blood vessels, using an electrically-activated glue patch applied via a minimally invasive balloon catheter.
› Verified 5 days ago
Vimal Sarup, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1309 E Ridge Rd Ste 1, Mcallen, TX 78503 Phone: 956-631-8875 Fax: 956-683-1502 | |
Dr. Rachel Ann Gelman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5201 N G St, Mcallen, TX 78504 Phone: 956-305-5795 Fax: 956-618-4639 | |
Dr. Raul Adrian Pena, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Ridge Rd Ste 10, Mcallen, TX 78503 Phone: 956-661-8733 Fax: 956-661-8724 | |
Dr. Melissa Ixcamey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1309 E Ridge Rd Ste 1, Mcallen, TX 78503 Phone: 956-844-6440 | |
Cooper M Clark, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1309 E Ridge Rd, Suite 1, Mcallen, TX 78503 Phone: 956-631-8875 Fax: 956-682-6280 | |
Dr. Wade Alan Graham, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Ridge Rd Ste 3, Mcallen, TX 78503 Phone: 956-429-4900 Fax: 956-429-4901 | |
Dr. Nehal Rashmikant Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1309 East Ridge Road, Suite 1, Mcallen, TX 78503 Phone: 956-631-8875 Fax: 956-631-9134 |